Meta-analysis of lymphocytes in schizophrenia

Clinical status and antipsychotic effects

Brian J. Miller, Bintou Gassama, Dale Sebastian, Peter Buckley, Andrew Mellor

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Background: Schizophrenia is associated with immune system dysfunction, including abnormal blood immune cell parameters. We performed a meta-analysis of these associations, considering the effect of clinical status and antipsychotic treatment following an acute exacerbation of psychosis. Methods: We identified articles by searching PubMed, PsycINFO, and Thomson Reuters (formerly ISI) Web of Knowledge and the reference lists of identified studies. Results: Sixteen studies of blood lymphocytes met the inclusion criteria. There was insufficient data for a meta-analysis of the mononuclear phagocytic system. In cross-sectional studies, there was a significant increase in the CD4% and CD56% in acutely relapsed inpatients. Absolute levels of total lymphocytes, CD3, and CD4, and the CD4/CD8 ratio were significantly increased, and the CD3% was significantly decreased in drug-native first-episode psychosis. In longitudinal studies, the CD4/CD8 ratio appeared to be state-related markers, as it decreased following antipsychotic treatment for acute exacerbations of psychosis. Absolute CD56 levels appeared to be a trait marker, as levels significantly increased following antipsychotic treatment for relapse. Conclusions: Blood lymphocyte abnormalities in drug-naïve first-episode psychosis suggest an effect that may be independent of antipsychotic medications. While some parameters (CD4/CD8) may be state markers for acute exacerbations of psychosis, others (CD56) may be trait markers; however, more longitudinal studies are needed. Although these findings could provide the basis for future hypothesis testing, a relatively small number of studies and subjects, lack of correlative data with clinical features, and inadequate consideration of potential confounding factors limit the results.

Original languageEnglish (US)
Pages (from-to)993-999
Number of pages7
JournalBiological Psychiatry
Volume73
Issue number10
DOIs
StatePublished - May 15 2013

Fingerprint

Psychotic Disorders
Antipsychotic Agents
Meta-Analysis
Schizophrenia
Lymphocytes
CD4-CD8 Ratio
Longitudinal Studies
PubMed
Pharmaceutical Preparations
Inpatients
Immune System
Blood Cells
Therapeutics
Cross-Sectional Studies
Recurrence

Keywords

  • First-episode psychosis
  • lymphocytes
  • meta-analysis
  • monocytes
  • relapse
  • schizophrenia

ASJC Scopus subject areas

  • Biological Psychiatry

Cite this

Meta-analysis of lymphocytes in schizophrenia : Clinical status and antipsychotic effects. / Miller, Brian J.; Gassama, Bintou; Sebastian, Dale; Buckley, Peter; Mellor, Andrew.

In: Biological Psychiatry, Vol. 73, No. 10, 15.05.2013, p. 993-999.

Research output: Contribution to journalArticle

Miller, Brian J. ; Gassama, Bintou ; Sebastian, Dale ; Buckley, Peter ; Mellor, Andrew. / Meta-analysis of lymphocytes in schizophrenia : Clinical status and antipsychotic effects. In: Biological Psychiatry. 2013 ; Vol. 73, No. 10. pp. 993-999.
@article{c4037616210546f9a6705c106fe9ccc7,
title = "Meta-analysis of lymphocytes in schizophrenia: Clinical status and antipsychotic effects",
abstract = "Background: Schizophrenia is associated with immune system dysfunction, including abnormal blood immune cell parameters. We performed a meta-analysis of these associations, considering the effect of clinical status and antipsychotic treatment following an acute exacerbation of psychosis. Methods: We identified articles by searching PubMed, PsycINFO, and Thomson Reuters (formerly ISI) Web of Knowledge and the reference lists of identified studies. Results: Sixteen studies of blood lymphocytes met the inclusion criteria. There was insufficient data for a meta-analysis of the mononuclear phagocytic system. In cross-sectional studies, there was a significant increase in the CD4{\%} and CD56{\%} in acutely relapsed inpatients. Absolute levels of total lymphocytes, CD3, and CD4, and the CD4/CD8 ratio were significantly increased, and the CD3{\%} was significantly decreased in drug-native first-episode psychosis. In longitudinal studies, the CD4/CD8 ratio appeared to be state-related markers, as it decreased following antipsychotic treatment for acute exacerbations of psychosis. Absolute CD56 levels appeared to be a trait marker, as levels significantly increased following antipsychotic treatment for relapse. Conclusions: Blood lymphocyte abnormalities in drug-na{\"i}ve first-episode psychosis suggest an effect that may be independent of antipsychotic medications. While some parameters (CD4/CD8) may be state markers for acute exacerbations of psychosis, others (CD56) may be trait markers; however, more longitudinal studies are needed. Although these findings could provide the basis for future hypothesis testing, a relatively small number of studies and subjects, lack of correlative data with clinical features, and inadequate consideration of potential confounding factors limit the results.",
keywords = "First-episode psychosis, lymphocytes, meta-analysis, monocytes, relapse, schizophrenia",
author = "Miller, {Brian J.} and Bintou Gassama and Dale Sebastian and Peter Buckley and Andrew Mellor",
year = "2013",
month = "5",
day = "15",
doi = "10.1016/j.biopsych.2012.09.007",
language = "English (US)",
volume = "73",
pages = "993--999",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Meta-analysis of lymphocytes in schizophrenia

T2 - Clinical status and antipsychotic effects

AU - Miller, Brian J.

AU - Gassama, Bintou

AU - Sebastian, Dale

AU - Buckley, Peter

AU - Mellor, Andrew

PY - 2013/5/15

Y1 - 2013/5/15

N2 - Background: Schizophrenia is associated with immune system dysfunction, including abnormal blood immune cell parameters. We performed a meta-analysis of these associations, considering the effect of clinical status and antipsychotic treatment following an acute exacerbation of psychosis. Methods: We identified articles by searching PubMed, PsycINFO, and Thomson Reuters (formerly ISI) Web of Knowledge and the reference lists of identified studies. Results: Sixteen studies of blood lymphocytes met the inclusion criteria. There was insufficient data for a meta-analysis of the mononuclear phagocytic system. In cross-sectional studies, there was a significant increase in the CD4% and CD56% in acutely relapsed inpatients. Absolute levels of total lymphocytes, CD3, and CD4, and the CD4/CD8 ratio were significantly increased, and the CD3% was significantly decreased in drug-native first-episode psychosis. In longitudinal studies, the CD4/CD8 ratio appeared to be state-related markers, as it decreased following antipsychotic treatment for acute exacerbations of psychosis. Absolute CD56 levels appeared to be a trait marker, as levels significantly increased following antipsychotic treatment for relapse. Conclusions: Blood lymphocyte abnormalities in drug-naïve first-episode psychosis suggest an effect that may be independent of antipsychotic medications. While some parameters (CD4/CD8) may be state markers for acute exacerbations of psychosis, others (CD56) may be trait markers; however, more longitudinal studies are needed. Although these findings could provide the basis for future hypothesis testing, a relatively small number of studies and subjects, lack of correlative data with clinical features, and inadequate consideration of potential confounding factors limit the results.

AB - Background: Schizophrenia is associated with immune system dysfunction, including abnormal blood immune cell parameters. We performed a meta-analysis of these associations, considering the effect of clinical status and antipsychotic treatment following an acute exacerbation of psychosis. Methods: We identified articles by searching PubMed, PsycINFO, and Thomson Reuters (formerly ISI) Web of Knowledge and the reference lists of identified studies. Results: Sixteen studies of blood lymphocytes met the inclusion criteria. There was insufficient data for a meta-analysis of the mononuclear phagocytic system. In cross-sectional studies, there was a significant increase in the CD4% and CD56% in acutely relapsed inpatients. Absolute levels of total lymphocytes, CD3, and CD4, and the CD4/CD8 ratio were significantly increased, and the CD3% was significantly decreased in drug-native first-episode psychosis. In longitudinal studies, the CD4/CD8 ratio appeared to be state-related markers, as it decreased following antipsychotic treatment for acute exacerbations of psychosis. Absolute CD56 levels appeared to be a trait marker, as levels significantly increased following antipsychotic treatment for relapse. Conclusions: Blood lymphocyte abnormalities in drug-naïve first-episode psychosis suggest an effect that may be independent of antipsychotic medications. While some parameters (CD4/CD8) may be state markers for acute exacerbations of psychosis, others (CD56) may be trait markers; however, more longitudinal studies are needed. Although these findings could provide the basis for future hypothesis testing, a relatively small number of studies and subjects, lack of correlative data with clinical features, and inadequate consideration of potential confounding factors limit the results.

KW - First-episode psychosis

KW - lymphocytes

KW - meta-analysis

KW - monocytes

KW - relapse

KW - schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84876951375&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876951375&partnerID=8YFLogxK

U2 - 10.1016/j.biopsych.2012.09.007

DO - 10.1016/j.biopsych.2012.09.007

M3 - Article

VL - 73

SP - 993

EP - 999

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 10

ER -